| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
7,311 |
6,299 |
$347K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,329 |
3,894 |
$147K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
572 |
515 |
$35K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
233 |
216 |
$11K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
378 |
354 |
$9K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
279 |
253 |
$7K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,356 |
739 |
$7K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
554 |
485 |
$7K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
141 |
109 |
$7K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
372 |
325 |
$5K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
237 |
214 |
$5K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
89 |
76 |
$5K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
847 |
758 |
$4K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
376 |
340 |
$4K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
55 |
51 |
$3K |
| 87634 |
|
63 |
55 |
$3K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,474 |
1,338 |
$3K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
84 |
82 |
$3K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
226 |
212 |
$2K |
| 92551 |
|
166 |
157 |
$1K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
13 |
12 |
$957.90 |
| 99188 |
|
50 |
47 |
$827.32 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
37 |
29 |
$670.41 |
| 36415 |
Collection of venous blood by venipuncture |
341 |
318 |
$528.23 |
| 99173 |
|
227 |
208 |
$350.42 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,706 |
1,547 |
$315.07 |
| 99401 |
|
250 |
164 |
$105.70 |
| 81002 |
|
47 |
42 |
$83.10 |
| 96127 |
|
25 |
13 |
$44.83 |
| 90710 |
|
14 |
14 |
$0.00 |
| 90670 |
|
87 |
72 |
$0.00 |
| 90633 |
|
18 |
16 |
$0.00 |